Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cblb612 (1 trial)
entolimod (1 trial)
Breast Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Neutropenia (Phase 2)
Trials (2 total)
Trial APIs (2 total)